Kenneth Dawson-Scully

Boca Raton, FL, United States of America

Kenneth Dawson-Scully

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Florida Atlantic University. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenneth Dawson-Scully. Retrieved from https://idiyas.com/inventor/kenneth-dawson-scully

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kenneth Dawson-Scully: Innovator in Neuroprotective Compounds

Introduction

Kenneth Dawson-Scully is a notable inventor based in Boca Raton, FL (US). He has made significant contributions to the field of neuroprotective agents, focusing on reducing neurological damage due to cellular stress. His innovative work has the potential to impact therapeutic approaches in neurology.

Latest Patents

Kenneth Dawson-Scully holds a patent for "Bridged bicyclic compounds and their derivatives as neuroprotective agents and methods of use thereof." This patent describes neuroprotective compounds that aim to reduce neurological damage in individuals experiencing cellular stress. The compounds are characterized by a specific formula that includes various aryl and alkyl substituents, which are crucial for their therapeutic effectiveness.

Career Highlights

Kenneth is affiliated with Florida Atlantic University, where he continues to advance his research in neuroprotection. His work is pivotal in exploring new methods to restore synaptic function during or after cellular stress, showcasing his commitment to improving neurological health.

Collaborations

Kenneth has collaborated with notable colleagues such as Salvatore Donato Lepore and Wesley L Bollinger. These partnerships enhance the research and development of neuroprotective compounds, fostering innovation in the field.

Conclusion

Kenneth Dawson-Scully's contributions to neuroprotective agents represent a significant advancement in the field of neurology. His innovative patent and ongoing research at Florida Atlantic University highlight his dedication to improving therapeutic outcomes for individuals facing neurological challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…